Purpose: It is difficult to obtain biopsies from gastrointestinal stromal tumors (GISTs) prior to surgery because GISTs are submucoal tumors, despite being the most common nonepithelial neoplasms of the gastrointestinal tract. Unlike anatomic imaging techniques, PET-CT, which is a molecular imaging tool, can be a useful technique for assessing tumor activity and predicting the malignant potential of certain tumors. Thus, we aimed to evaluate the usefulness of PET-CT as a pre-operative prognostic factor for GISTs by analyzing the correlation between the existing post-operative prognostic factors and the maximum SUV uptake (SUVmax) of pre-operative 18F-fluoro-2-deoxyglucose (FDG) PET-CT. Materials and Methods: The study was conducted on 26 patients who were diagnosed with gastric GISTs and underwent surgery after being examined with pre-operative FDG PET-CT. An analysis of the correlation bewteen (i) NIH risk classfication and the Ki-67 proliferation index, which are post-operative prognostic factors, and (ii) the SUVmax of PET-CT, which is a pre-operative prognostic factor, was performed.
. However, there is no method with which to predict the pre-operative prognosis for GISTs, with the exception of measuring tumor size using anatomic imaging techniques, such as computed tomography (CT), endoscopic ultrasonography (EUS), and magnetic resonance imaging (MRI).
Recently, the use of PET-CT as a non-invasive diagnostic tool in oncology for diagnosis and staging, as well as a technique to determine prognosis and the best course of treatment, has increased. PET-CT is expected to be useful as a non-invasive tool, especially for GISTs, because the pre-operative diagnosis, staging, and prediction of prognosis of GISTs is not easy. (11, 12) Indeed, all GISTs have the potential for malignant transformation and there is no pre-operative diagnostic method that distinguishes GISTs from submucosal tumors.
The objective of the current study was to determine if PET-CT is clinically useful for predicting the pre-operative prognosis of GISTs by comparing the pre-operative maximum standardized uptake value (SUV) uptake (SUVmax) of the 18F-fluoro-2-deoxyglucose (FDG) PET-CT, which is a molecular imaging tool, with existing post-operative prognostic factors, such as the tumor size, mitotic count, and Ki-67 proliferation index, which is an immunologic index.
Materials and Methods

Patients
The study was conducted on 26 of 27 patients who were diag- 
Diagnosis of gastric GIST
After the FDG PET-CT study, each patient underwent tumor resection. Eleven patients had laparoscopic wedge resections of the stomach, 13 patients had open wedge resections, and 2 patients had gastrectomies. Post-operatively, GIST was diagnosed by positive staining of c-kit, CD34, or both.
Ki-67 Immunohistochemisty
The surgical specimens were fixed with 10% neutral buffered formalin and embedded in paraffin blocks. Hematoxylin and eosin staining were performed. Immunohistochemical staining for c-kit and CD34 was performed by the standard avidin-biotin peroxidase complex method, and the Ki-67 proliferation index was determined. The Ki-67 index was defined as the percentage of nuclearstained tumor cells per 1,000 tumor cells and evaluated by 1 pathologist to reduce bias. 
Results
Clinical characteristics of the patients
The clinico-pathologic characteristics of the 26 patients studied are summarized in Table 2 . We studied 26 patients (10 males and 16 females) with a GIST of the stomach. The mean age was 62.04 ±11.4 years. All tumors stained positive for c-kit, CD 34, or both.
FDG uptake was found demonstrated in all cases.
GISTs were primarily located in the proximal body (12 
Relationship between maximum SUV uptake and clinicopathologic characteristics
The relationships between the maximum SUV uptake and the clinicopathologic characteristics of gastric GISTs, including tumor size, Ki-67 index, mitotic count, and NIH risk group, are shown in Table 3 . As a result of an analysis of the correlation between the maximum SUV and other prognostic factors, the correlation coefficient of the MSU with Ki-67, mitotic count, tumor size, and NIH risk classification was 0.854 (P=0.000), 0.888 (P=0.000), 0.791 (P=0.000), and 0.756 (P=0.000), respectively (Fig. 1) . HPF = high-power fi elds; SD = standard deviation. *Size is the single largest dimension.
Evaluation of the cut-off value
tential, we classified the NIH risk classification as "low-risk malignancy" (very low-risk and low-risk) and "high-risk malignancy" groups (intermediate-risk and high-risk), and calculated the cutoff point. The cut-off value of the MSU was 3.94 between the "low-risk malignancy" and "high-risk malignancy" groups and the area under the ROC curve was 0.872. The sensitivity and speci- ( [24] [25] [26] In the current study, we noted a significant correlation between the Ki-67 index and SUV uptake (r=0.854, P＜0.001), thus a high SUV uptake can be high cell proliferation, and higher aggressiveness and invasiveness; We therefore hypothesized that elevated SUV values occur in highly proliferative GISTs, and the results of the current study supported our hypothesis.
GISTs could be classified as low-(very low-or low-risk) and high-risk for malignancy (intermediate-or high-risk) groups.
(10) We investigated the association between the MSU and risk categories based on morphologic features, including mitotic rate and tumor size by using ROC curves. The cut-off value of the MSU was 3.94 between very low-and low-, and intermediate- Fig. 2 . Receiver operator characteristic (ROC) curves generated with maximum SUV uptake. Th e cut-off value of the MSU was 3.94 between the "low-risk malignancy" and "high-risk malignancy" groups and the area under the ROC curve was 0.872.
and high-risk groups based on the NIH risk classification (Fig.   2 ). With a similar aim, Yamada et al. (27) FDG PET is a non-invasive modality. If a GIST shows heterogeneity, the metabolically active tissue can be distinguished from necrotic tissue by imaging the entire tumor in three dimensions.
The maximum SUV of the tumor, rather than the average SUV, must be adopted for the analysis because the most metabolicallyactive regions of the tumor drive the overall behavior of the tumor and averaging active areas with areas of cystic change or necrosis (areas with a very low SUV) would result in falsely low overall values. (24) In the current study, therefore, one nuclear radiologist calculated the maximum SUV of the tumors in order to reduce bias.
In conclusion, The FDG PET scan is useful for assessing the bioactivity of gastric GISTs and less invasive than other techniques.
Furthermore, it is easier to evaluate the malignant potential of gastric GISTs, and the sensitivity and specificity predicting risk of malignancy were 85.7% and 94.7%, respectively, if a FDG-PET scan is used before surgery. It is reasonable to expect a gastric GIST with a high FDG uptake to have malignant potential.
